MARKET

SPHRF

SPHRF

Starpharma Holdings Ltd
OTCMQB
0.056
NaN%
Opening 09:30 12/09 EST
OPEN
--
PREV CLOSE
0.056
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.077
52 WEEK LOW
0.056
MARKET CAP
23.34M
P/E (TTM)
-3.5541
1D
5D
1M
3M
1Y
5Y
1D
Starpharma Announces Successful 2025 AGM Results
TipRanks · 11/14 05:30
Starpharma Announces Strategic Partnerships and Growth at AGM
TipRanks · 11/14 03:08
Starpharma Secures Key Partnerships and Advances Strategic Initiatives in Q1 FY26
TipRanks · 10/28 00:09
Starpharma Receives $5.5 Million Upfront Payment from Genentech for Oncology Collaboration
TipRanks · 10/22 01:59
Starpharma Showcases Strategic Advances in Oncology Drug Delivery
TipRanks · 10/21 04:57
Starpharma Director Increases Shareholding
TipRanks · 10/21 02:48
Starpharma Announces 2025 AGM with Hybrid Participation
Barchart · 10/13 19:30
Starpharma Director’s Performance Rights Adjusted
Barchart · 10/06 20:14
More
About SPHRF
Starpharma Holdings Limited is an Australia-based biotechnology company specializing in advancing dendrimer technology. The Company's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The Company's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. It also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The Company has applied its DEP technology to the innovative area of antibody-drug conjugates.

Webull offers Starpharma Holdings Ltd stock information, including OTCMQB: SPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPHRF stock methods without spending real money on the virtual paper trading platform.